Pharmaceutical Research and Manufacturers of America (PhRMA)
DC · US
Tracked direct giving exceeds tracked direct receipts by
$220,528
The pharmaceutical industry's trade association, representing the research-based drug makers. Its LDA filings, PAC and state-filing contributor rows are consolidated here.
Tracked direct giving
$226,776
Tracked receipts
$6,248
LDA reported lobbying spend
$83,968,550
Connections
62
Coalition view
Pharmaceutical Research and Manufacturers of America (PhRMA) operates as part of a multi-committee coalition with PhRMA PAC. Combined tracked totals across all coalition members below give the figure most public sources quote (Sludge, JNS, OpenSecrets).
Combined direct giving + IE support
$770,552
Combined tracked receipts
$295,878
Combined lobbying spend
$141,333,550
How money flowed from Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical Research and Manufacturers of America (PhRMA) directed $100K to Emanuel "Chris" Welch across 4 contributions between November 2023 and September 2026. Pharmaceutical Research and Manufacturers of America (PhRMA) advocates for Medicare Drug Price Negotiation - First 10 Drugs Selected.
Pharmaceutical Research and Manufacturers of America (PhRMA) directed $90K to Don Harmon (Illinois) across 3 contributions between November 2023 and September 2026. Pharmaceutical Research and Manufacturers of America (PhRMA) advocates for Medicare Drug Price Negotiation - First 10 Drugs Selected.
Pharmaceutical Research and Manufacturers of America (PhRMA) directed $10K to John Curran (Illinois). Pharmaceutical Research and Manufacturers of America (PhRMA) advocates for Medicare Drug Price Negotiation - First 10 Drugs Selected.
Pharmaceutical Research and Manufacturers of America (PhRMA) directed $10K to Tony McCombie. Pharmaceutical Research and Manufacturers of America (PhRMA) advocates for Medicare Drug Price Negotiation - First 10 Drugs Selected.
Pharmaceutical Research and Manufacturers of America (PhRMA) directed $5K to Jeff Landry. Pharmaceutical Research and Manufacturers of America (PhRMA) advocates for Medicare Drug Price Negotiation - First 10 Drugs Selected.
Pharmaceutical Research and Manufacturers of America (PhRMA) also gave to 3 other entities totaling $6K.
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
Lobbying Firms Retained
Bills Referenced in Lobbying Filings
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Click a node to see details
Double-click to expand its connections
Donations Given and Outside Spending
Largest 50 records. Rows badged “Spent to support” or “Spent to oppose” are independent expenditures this entity paid to vendors for or against the named candidate. That money was not given to them.
Donations Received and Outside Spending
Largest 50 records. Badged rows are independent expenditures other groups paid to vendors for or against this entity. That money did not reach its committee.
| Donor | Amount | Date | Cycle |
|---|---|---|---|
| Merck & Co. Inc. PAC | $5,000 | Sep 15, 2024 | 2024 |
| NIKKI FOR CONGRESS | $1,248 | Aug 7, 2024 | 2024 |
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | AKIN GUMP STRAUSS HAUER & FELD | Hired AKIN GUMP STRAUSS HAUER & FELD to lobby on PBM Reform Act | Source |
| Lobbied on | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $50,000 | Source |
| Retained | EMPIRE CONSULTING GROUP | Hired EMPIRE CONSULTING GROUP to lobby on Insulin Price Caps | Source |
| Retained | Public Strategies Washington | Hired PUBLIC STRATEGIES WASHINGTON, INC. to lobby on Pharmaceuticals | Source |
| Retained | DLA PIPER LLP (US) | Hired DLA PIPER LLP (US) to lobby on Pharmaceuticals | Source |
| Retained | TIBER CREEK HEALTH STRATEGIES, INC. | Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on Pharmaceuticals | Source |
| Retained | CROSSROADS STRATEGIES, LLC | Hired CROSSROADS STRATEGIES, LLC to lobby on Pharmaceuticals | Source |
| Retained | LMH STRATEGIC SOLUTIONS | Hired LMH STRATEGIC SOLUTIONS to lobby on Pharmaceuticals | Source |
| Retained | AEGIS LLC | Hired AEGIS LLC to lobby on Pharmaceuticals | Source |
| Retained | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on Pharmaceuticals | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $40,000 | Source |
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Lobbied on | BIOSECURE Act (H.R.8333/S.3558) | LDA filing: lobbied on BIOSECURE Act, period 4th Quarter (Oct 1 - Dec 31), reported amount $7,560,000 | Source |
| Lobbied on | Ukraine Security Assistance Supplemental | LDA filing: lobbied on Ukraine Security Supplemental, period 1st Quarter (Jan 1 - Mar 31), reported amount $7,990,000 | Source |
| Lobbied on | Sugar Reform Act (S.832, 118th Congress) | LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $12,880,000 | Source |
| Commented on | Federal Trade Commission | Public comment on FTC-2023-0040: Premerger Notification; Reporting and Waiting Period Requirements | Source |
| Funded research at | The Heritage Foundation | PhRMA funds Heritage health policy research | Editorial |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-0058: Transparency in Coverage CMS-9882-P | Source |
| Retained | NELSON MULLINS RILEY & SCARBOROUGH | Hired NELSON MULLINS RILEY & SCARBOROUGH to lobby on Pharmaceuticals | Source |
| Retained | TODD STRATEGY GROUP | Hired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | FARRAGUT PARTNERS LLP | Hired FARRAGUT PARTNERS LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | LESIC AND CAMPER COMMUNICATIONS | Hired LESIC AND CAMPER COMMUNICATIONS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | THORN RUN PARTNERS | Hired THORN RUN PARTNERS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | RADIUS ADVOCACY, LLC | Hired RADIUS ADVOCACY, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | BOSE PUBLIC AFFAIRS GROUP | Hired BOSE PUBLIC AFFAIRS GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | EAST END GROUP, LLC | Hired EAST END GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | FEDERAL HEALTH COUNSEL, LLC | Hired FEDERAL HEALTH COUNSEL, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | BGR GOVERNMENT AFFAIRS | Hired BGR GOVERNMENT AFFAIRS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | BRAVO GROUP | Hired BRAVO GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | W STRATEGIES, LLC | Hired W STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | THE MCMANUS GROUP | Hired THE MCMANUS GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | SL STRATEGIES, LLC | Hired SL STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | ALTRIUS GROUP, LLC | Hired ALTRIUS GROUP, LLC to lobby (3rd Quarter (July 1 - Sep 30) 2023) | Source |
| Retained | MILLER STRATEGIES, LLC | Hired MILLER STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | YC CONSULTING, LLC | Hired YC CONSULTING, LLC to lobby (4th Quarter (Oct 1 - Dec 31) 2023) | Source |
| Retained | HORIZON GOVERNMENT AFFAIRS | Hired HORIZON GOVERNMENT AFFAIRS to lobby on Pharmaceuticals | Source |
| Retained | TIBER CREEK GROUP | Hired TIBER CREEK GROUP to lobby on Pharmaceuticals | Source |
| Retained | FORBES-TATE | Hired FORBES-TATE to lobby on Pharmaceuticals | Source |
| Retained | HILLNORTH LLC | Hired HILLNORTH LLC to lobby on Pharmaceuticals | Source |
| Retained | CONVERGENCE PUBLIC AFFAIRS LLC | Hired CONVERGENCE PUBLIC AFFAIRS LLC to lobby on Pharmaceuticals | Source |
| Retained | WILLIAMS AND JENSEN, PLLC | Hired WILLIAMS AND JENSEN, PLLC to lobby on Sugar Reform Act | Source |
| Commented on | Department of Health and Human Services | Public comment on HHS-OS-2015-0005: Health Information Technology Certification Criteria, Base Electronic Health Record Definition, and ONC Health IT Certification Program Modifications | Source |
| Retained | MR. VINCENT A. PANVINI | Hired MR. VINCENT A. PANVINI to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | NVG, LLC | Hired NVG, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | MONUMENT ADVOCACY | Hired MONUMENT ADVOCACY to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | HANCE SCARBOROUGH | Hired HANCE SCARBOROUGH to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | Dentons US | Hired DENTONS US LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | TARPLIN, DOWNS & YOUNG, LLC | Hired TARPLIN, DOWNS & YOUNG, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | THE MATHIS HARPLE GROUP | Hired THE MATHIS HARPLE GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | ADAMS AND REESE, LLP | Hired ADAMS AND REESE, LLP to lobby (4th Quarter (Oct 1 - Dec 31) 2023) | Source |
| Retained | RUBIN, TURNBULL & ASSOCIATES | Hired RUBIN, TURNBULL & ASSOCIATES to lobby (1st Quarter (Jan 1 - Mar 31) 2025) | Source |
| Retained | ALPINE GROUP PARTNERS, LLC. | Hired ALPINE GROUP PARTNERS, LLC. to lobby (1st Quarter (Jan 1 - Mar 31) 2026) | Source |
| Retained | Covington & Burling LLP | Hired COVINGTON & BURLING LLP to lobby on BIOSECURE Act | Source |
| Advocated for | Medicare Drug Price Negotiation - First 10 Drugs Selected | PhRMA and member companies filed lawsuits challenging Medicare drug price negotiation | Source |
| Retained | ADVANCED POLICY CONSULTING, LLC | Hired ADVANCED POLICY CONSULTING, LLC to lobby on PBM Reform Act | Source |
| Retained | DESIMONE CONSULTING, LLC | Hired DESIMONE CONSULTING, LLC to lobby on PBM Reform Act | Source |
| Retained | OGR | Hired OGR to lobby on Insulin Price Caps | Source |
| Funded research at | American Enterprise Institute | PhRMA funds AEI pharmaceutical regulation research | Editorial |
| Funded research at | The Brookings Institution | PhRMA funds Brookings health policy research | Editorial |
| Instrument of | Pharmaceutical industry | PhRMA is the flagship lobbying organization for brand-name drug manufacturers | Editorial |
| Has as instrument | PhRMA PAC | Political action committee affiliated with PHRMA. | Editorial |
| Employed | Stephen Ubl | President and CEO of PhRMA since 2015 | Editorial |